Essentra Past Earnings Performance
Past criteria checks 1/6
Essentra's earnings have been declining at an average annual rate of -57.8%, while the Chemicals industry saw earnings growing at 3.2% annually. Revenues have been declining at an average rate of 31.4% per year. Essentra's return on equity is 0.2%, and it has net margins of 0.2%.
Key information
-57.8%
Earnings growth rate
-59.6%
EPS growth rate
Chemicals Industry Growth | 4.3% |
Revenue growth rate | -31.4% |
Return on equity | 0.2% |
Net Margin | 0.2% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Essentra plc (LON:ESNT) Shares Could Be 42% Below Their Intrinsic Value Estimate
Sep 20We Think You Should Be Aware Of Some Concerning Factors In Essentra's (LON:ESNT) Earnings
Mar 27Essentra (LON:ESNT) Is Reducing Its Dividend To £0.012
Aug 19Essentra plc (LON:ESNT) Shares Could Be 26% Above Their Intrinsic Value Estimate
Feb 03Essentra (LON:ESNT) Has A Somewhat Strained Balance Sheet
Dec 24Estimating The Intrinsic Value Of Essentra plc (LON:ESNT)
Nov 03Essentra's (LON:ESNT) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 11Essentra (LON:ESNT) Will Pay A Larger Dividend Than Last Year At £0.023
Aug 20Is It Too Late To Consider Buying Essentra plc (LON:ESNT)?
Jul 14Returns On Capital At Essentra (LON:ESNT) Paint A Concerning Picture
Jun 14Are Investors Undervaluing Essentra plc (LON:ESNT) By 41%?
May 25Here's Why Essentra (LON:ESNT) Can Manage Its Debt Responsibly
May 07Essentra (LON:ESNT) Is Increasing Its Dividend To UK£0.04
Mar 21Is Now The Time To Look At Buying Essentra plc (LON:ESNT)?
Mar 08Essentra's (LON:ESNT) Returns On Capital Tell Us There Is Reason To Feel Uneasy
Dec 29Is It Time To Consider Buying Essentra plc (LON:ESNT)?
Dec 07We Think Essentra (LON:ESNT) Can Stay On Top Of Its Debt
Sep 11A Look At The Fair Value Of Essentra plc (LON:ESNT)
Jul 02What Does Essentra plc's (LON:ESNT) Share Price Indicate?
Jun 14Is Essentra (LON:ESNT) Using Too Much Debt?
May 15Essentra's (LON:ESNT) Returns On Capital Tell Us There Is Reason To Feel Uneasy
Mar 23Revenue & Expenses Breakdown
How Essentra makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 310 | 1 | 0 | 0 |
31 Mar 24 | 313 | 3 | 0 | 0 |
31 Dec 23 | 316 | 6 | 0 | 0 |
30 Sep 23 | 322 | -6 | 0 | 0 |
30 Jun 23 | 328 | -17 | 0 | 0 |
31 Mar 23 | 333 | -26 | 0 | 0 |
31 Dec 22 | 338 | -35 | 0 | 0 |
30 Sep 22 | 264 | -31 | 0 | 0 |
30 Jun 22 | 190 | -27 | 0 | 0 |
31 Mar 22 | 246 | -17 | 0 | 0 |
31 Dec 21 | 302 | -6 | 0 | 0 |
30 Sep 21 | 519 | -2 | 1 | 0 |
30 Jun 21 | 736 | 1 | 1 | 0 |
31 Mar 21 | 816 | -1 | 1 | 0 |
31 Dec 20 | 897 | -3 | 1 | 0 |
30 Sep 20 | 906 | 9 | 1 | 0 |
30 Jun 20 | 916 | 14 | 1 | 0 |
31 Mar 20 | 945 | 26 | 1 | 0 |
31 Dec 19 | 974 | 38 | 1 | 0 |
30 Sep 19 | 997 | 39 | 1 | 0 |
30 Jun 19 | 1,019 | 40 | 1 | 0 |
31 Mar 19 | 1,022 | 32 | 1 | 0 |
31 Dec 18 | 1,026 | 24 | 1 | 0 |
30 Jun 18 | 1,018 | 4 | 1 | 0 |
31 Mar 18 | 1,023 | 4 | 1 | 0 |
31 Dec 17 | 1,027 | 4 | 1 | 0 |
30 Jun 17 | 1,026 | -64 | 1 | 0 |
31 Mar 17 | 1,012 | -58 | 0 | 0 |
31 Dec 16 | 999 | -52 | 0 | 0 |
30 Jun 16 | 951 | 48 | -3 | 0 |
31 Mar 16 | 979 | 52 | -1 | 0 |
31 Dec 15 | 1,007 | 56 | 0 | 0 |
30 Sep 15 | 1,042 | 69 | 236 | 0 |
30 Jun 15 | 985 | 71 | 202 | 0 |
31 Mar 15 | 925 | 71 | 201 | 0 |
31 Dec 14 | 866 | 71 | 201 | 0 |
30 Sep 14 | 855 | 68 | 195 | 0 |
30 Jun 14 | 845 | 64 | 189 | 0 |
31 Mar 14 | 821 | 62 | 188 | 0 |
31 Dec 13 | 798 | 60 | 187 | 0 |
Quality Earnings: ESNT has a large one-off loss of £5.3M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: ESNT became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ESNT's earnings have declined by 57.8% per year over the past 5 years.
Accelerating Growth: ESNT has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: ESNT has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-13%).
Return on Equity
High ROE: ESNT's Return on Equity (0.2%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/20 12:48 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Essentra plc is covered by 21 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Calum Battersby | Berenberg |
James Bayliss | Berenberg |
Michael O'Brien | Canaccord Genuity |